drugset / Trial / NCT06162494
Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients
Phase 4
Enrolling by invitation
80 enrolled
Ann & Robert H Lurie Children's Hospital of Chicago
Children's Hospital Colorado · collabChildren's Hospital Medical Center, Cincinnati · collab
NaSingle-groupOpen-labelPrevention
Summary
This goal of this study is to assess the safety and immunogenicity of recombinant zoster virus in young adult solid organ transplant recipients. In this study, participants will receive the recombinant zoster vaccine. They will be monitored for adverse events and tested for antibody and cellular immunity.
Timeline
- Start
- 2024-03-18
- Primary completion
- 2027-03-31
- Completion
- 2028-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VARICELLA ZOSTER VIRUS ENVELOPE GLYCOPROTEIN E | Vaccine | — | — |